Selected research
Industry Research
Topical Anti-infective Drugs Industry Research Report 2026
Market perspective
The global Topical Anti-infective Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Topical Anti-infective Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Topical Anti-infective Drugs market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Topical Anti-infective Drugs market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Topical Anti-infective Drugs include SK-SF, Zhejiang Funo Pharmaceuticals, Teva, Sun Pharmaceutical, Shandong Jingwei Pharmaceuticals, Sandoz, J & J, Liaoning Xingao Pharmaceuticals and Jiangsu Zhiyuan Pharmaceuticals, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Topical Anti-infective Drugs market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Topical Anti-infective Drugs.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Topical Anti-infective Drugs Market by Company
SK-SF
Zhejiang Funo Pharmaceuticals
Teva
Sun Pharmaceutical
Shandong Jingwei Pharmaceuticals
Sandoz
J & J
Liaoning Xingao Pharmaceuticals
Jiangsu Zhiyuan Pharmaceuticals
Jiangsu Fubang Pharmaceuticals
Hubei Renfu
Bayer
STADA Arzneimittel
LEO Pharma
Kaken Pharmaceutical
Haleon
Glenmark Pharmaceuticals
Galderma
Bausch Health
Almirall
Topical Anti-infective Drugs Segment by Type
Ointment
Solution
Gel
Other
Topical Anti-infective Drugs Segment by Application
Hospital
Retail Phamracy
Other
Topical Anti-infective Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Anti-infective Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Topical Anti-infective Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Anti-infective Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Topical Anti-infective Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ointment
- Solution
- Gel
- Other
Applications
- Hospital
- Retail Phamracy
- Other
Companies covered
- SK-SF
- Zhejiang Funo Pharmaceuticals
- Teva
- Sun Pharmaceutical
- Shandong Jingwei Pharmaceuticals
- Sandoz
- J & J
- Liaoning Xingao Pharmaceuticals
- Jiangsu Zhiyuan Pharmaceuticals
- Jiangsu Fubang Pharmaceuticals
- Hubei Renfu
- Bayer
- STADA Arzneimittel
- LEO Pharma
- Kaken Pharmaceutical
- Haleon
- Glenmark Pharmaceuticals
- Galderma
- Bausch Health
- Almirall
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Topical Anti-infective Drugs by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Ointment
- 2.2.3 Solution
- 2.2.4 Gel
- 2.2.5 Other
- 2.3 Topical Anti-infective Drugs by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Retail Phamracy
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Topical Anti-infective Drugs Breakdown Data by Type
- 3.1 Global Topical Anti-infective Drugs Historic Market Size by Type (2021-2026)
- 3.2 Global Topical Anti-infective Drugs Forecasted Market Size by Type (2027-2032)
4 Topical Anti-infective Drugs Breakdown Data by Application
- 4.1 Global Topical Anti-infective Drugs Historic Market Size by Application (2021-2026)
- 4.2 Global Topical Anti-infective Drugs Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Topical Anti-infective Drugs Market Perspective (2021-2032)
- 5.2 Global Topical Anti-infective Drugs Growth Trends by Region
- 5.2.1 Global Topical Anti-infective Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Topical Anti-infective Drugs Historic Market Size by Region (2021-2026)
- 5.2.3 Topical Anti-infective Drugs Forecasted Market Size by Region (2027-2032)
- 5.3 Topical Anti-infective Drugs Market Dynamics
- 5.3.1 Topical Anti-infective Drugs Industry Trends
- 5.3.2 Topical Anti-infective Drugs Market Drivers
- 5.3.3 Topical Anti-infective Drugs Market Challenges
- 5.3.4 Topical Anti-infective Drugs Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Topical Anti-infective Drugs Players by Revenue
- 6.1.1 Global Top Topical Anti-infective Drugs Players by Revenue (2021-2026)
- 6.1.2 Global Topical Anti-infective Drugs Revenue Market Share by Players (2021-2026)
- 6.2 Global Topical Anti-infective Drugs Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Topical Anti-infective Drugs Head Office and Area Served
- 6.4 Global Topical Anti-infective Drugs Players, Product Type & Application
- 6.5 Global Topical Anti-infective Drugs Manufacturers Established Date
- 6.6 Global Topical Anti-infective Drugs Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Topical Anti-infective Drugs Market Size (2021-2032)
- 7.2 North America Topical Anti-infective Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Topical Anti-infective Drugs Market Size by Country (2021-2026)
- 7.4 North America Topical Anti-infective Drugs Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Topical Anti-infective Drugs Market Size (2021-2032)
- 8.2 Europe Topical Anti-infective Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Topical Anti-infective Drugs Market Size by Country (2021-2026)
- 8.4 Europe Topical Anti-infective Drugs Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Topical Anti-infective Drugs Market Size (2021-2032)
- 9.2 Asia-Pacific Topical Anti-infective Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Topical Anti-infective Drugs Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Topical Anti-infective Drugs Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Topical Anti-infective Drugs Market Size (2021-2032)
- 10.2 South America Topical Anti-infective Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Topical Anti-infective Drugs Market Size by Country (2021-2026)
- 10.4 South America Topical Anti-infective Drugs Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Topical Anti-infective Drugs Market Size (2021-2032)
- 11.2 Middle East & Africa Topical Anti-infective Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Topical Anti-infective Drugs Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Topical Anti-infective Drugs Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 SK-SF
- 12.1.1 SK-SF Company Information
- 12.1.2 SK-SF Business Overview
- 12.1.3 SK-SF Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.1.4 SK-SF Topical Anti-infective Drugs Product Portfolio
- 12.1.5 SK-SF Recent Developments
- 12.2 Zhejiang Funo Pharmaceuticals
- 12.2.1 Zhejiang Funo Pharmaceuticals Company Information
- 12.2.2 Zhejiang Funo Pharmaceuticals Business Overview
- 12.2.3 Zhejiang Funo Pharmaceuticals Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.2.4 Zhejiang Funo Pharmaceuticals Topical Anti-infective Drugs Product Portfolio
- 12.2.5 Zhejiang Funo Pharmaceuticals Recent Developments
- 12.3 Teva
- 12.3.1 Teva Company Information
- 12.3.2 Teva Business Overview
- 12.3.3 Teva Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.3.4 Teva Topical Anti-infective Drugs Product Portfolio
- 12.3.5 Teva Recent Developments
- 12.4 Sun Pharmaceutical
- 12.4.1 Sun Pharmaceutical Company Information
- 12.4.2 Sun Pharmaceutical Business Overview
- 12.4.3 Sun Pharmaceutical Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.4.4 Sun Pharmaceutical Topical Anti-infective Drugs Product Portfolio
- 12.4.5 Sun Pharmaceutical Recent Developments
- 12.5 Shandong Jingwei Pharmaceuticals
- 12.5.1 Shandong Jingwei Pharmaceuticals Company Information
- 12.5.2 Shandong Jingwei Pharmaceuticals Business Overview
- 12.5.3 Shandong Jingwei Pharmaceuticals Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.5.4 Shandong Jingwei Pharmaceuticals Topical Anti-infective Drugs Product Portfolio
- 12.5.5 Shandong Jingwei Pharmaceuticals Recent Developments
- 12.6 Sandoz
- 12.6.1 Sandoz Company Information
- 12.6.2 Sandoz Business Overview
- 12.6.3 Sandoz Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.6.4 Sandoz Topical Anti-infective Drugs Product Portfolio
- 12.6.5 Sandoz Recent Developments
- 12.7 J & J
- 12.7.1 J & J Company Information
- 12.7.2 J & J Business Overview
- 12.7.3 J & J Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.7.4 J & J Topical Anti-infective Drugs Product Portfolio
- 12.7.5 J & J Recent Developments
- 12.8 Liaoning Xingao Pharmaceuticals
- 12.8.1 Liaoning Xingao Pharmaceuticals Company Information
- 12.8.2 Liaoning Xingao Pharmaceuticals Business Overview
- 12.8.3 Liaoning Xingao Pharmaceuticals Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.8.4 Liaoning Xingao Pharmaceuticals Topical Anti-infective Drugs Product Portfolio
- 12.8.5 Liaoning Xingao Pharmaceuticals Recent Developments
- 12.9 Jiangsu Zhiyuan Pharmaceuticals
- 12.9.1 Jiangsu Zhiyuan Pharmaceuticals Company Information
- 12.9.2 Jiangsu Zhiyuan Pharmaceuticals Business Overview
- 12.9.3 Jiangsu Zhiyuan Pharmaceuticals Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.9.4 Jiangsu Zhiyuan Pharmaceuticals Topical Anti-infective Drugs Product Portfolio
- 12.9.5 Jiangsu Zhiyuan Pharmaceuticals Recent Developments
- 12.10 Jiangsu Fubang Pharmaceuticals
- 12.10.1 Jiangsu Fubang Pharmaceuticals Company Information
- 12.10.2 Jiangsu Fubang Pharmaceuticals Business Overview
- 12.10.3 Jiangsu Fubang Pharmaceuticals Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.10.4 Jiangsu Fubang Pharmaceuticals Topical Anti-infective Drugs Product Portfolio
- 12.10.5 Jiangsu Fubang Pharmaceuticals Recent Developments
- 12.11 Hubei Renfu
- 12.11.1 Hubei Renfu Company Information
- 12.11.2 Hubei Renfu Business Overview
- 12.11.3 Hubei Renfu Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.11.4 Hubei Renfu Topical Anti-infective Drugs Product Portfolio
- 12.11.5 Hubei Renfu Recent Developments
- 12.12 Bayer
- 12.12.1 Bayer Company Information
- 12.12.2 Bayer Business Overview
- 12.12.3 Bayer Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.12.4 Bayer Topical Anti-infective Drugs Product Portfolio
- 12.12.5 Bayer Recent Developments
- 12.13 STADA Arzneimittel
- 12.13.1 STADA Arzneimittel Company Information
- 12.13.2 STADA Arzneimittel Business Overview
- 12.13.3 STADA Arzneimittel Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.13.4 STADA Arzneimittel Topical Anti-infective Drugs Product Portfolio
- 12.13.5 STADA Arzneimittel Recent Developments
- 12.14 LEO Pharma
- 12.14.1 LEO Pharma Company Information
- 12.14.2 LEO Pharma Business Overview
- 12.14.3 LEO Pharma Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.14.4 LEO Pharma Topical Anti-infective Drugs Product Portfolio
- 12.14.5 LEO Pharma Recent Developments
- 12.15 Kaken Pharmaceutical
- 12.15.1 Kaken Pharmaceutical Company Information
- 12.15.2 Kaken Pharmaceutical Business Overview
- 12.15.3 Kaken Pharmaceutical Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.15.4 Kaken Pharmaceutical Topical Anti-infective Drugs Product Portfolio
- 12.15.5 Kaken Pharmaceutical Recent Developments
- 12.16 Haleon
- 12.16.1 Haleon Company Information
- 12.16.2 Haleon Business Overview
- 12.16.3 Haleon Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.16.4 Haleon Topical Anti-infective Drugs Product Portfolio
- 12.16.5 Haleon Recent Developments
- 12.17 Glenmark Pharmaceuticals
- 12.17.1 Glenmark Pharmaceuticals Company Information
- 12.17.2 Glenmark Pharmaceuticals Business Overview
- 12.17.3 Glenmark Pharmaceuticals Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.17.4 Glenmark Pharmaceuticals Topical Anti-infective Drugs Product Portfolio
- 12.17.5 Glenmark Pharmaceuticals Recent Developments
- 12.18 Galderma
- 12.18.1 Galderma Company Information
- 12.18.2 Galderma Business Overview
- 12.18.3 Galderma Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.18.4 Galderma Topical Anti-infective Drugs Product Portfolio
- 12.18.5 Galderma Recent Developments
- 12.19 Bausch Health
- 12.19.1 Bausch Health Company Information
- 12.19.2 Bausch Health Business Overview
- 12.19.3 Bausch Health Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.19.4 Bausch Health Topical Anti-infective Drugs Product Portfolio
- 12.19.5 Bausch Health Recent Developments
- 12.20 Almirall
- 12.20.1 Almirall Company Information
- 12.20.2 Almirall Business Overview
- 12.20.3 Almirall Revenue in Topical Anti-infective Drugs Business (2021-2026)
- 12.20.4 Almirall Topical Anti-infective Drugs Product Portfolio
- 12.20.5 Almirall Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst